TTNP Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

Open

VWAP

Vol

Mkt Cap

5.07M

Low

Amount

EV/EBITDA(TTM)

Total Shares

31.25M

EV/OCF(TTM)

P/S(TTM)

Titan Pharmaceuticals, Inc. is a pharmaceutical company. Its product pipeline includes Kappa Opioid Receptor Agonist (TP-2021) Implant, which is used for the treatment of moderate-to-severe chronic pruritus, and Nalmefene Implant, which is for the prevention of relapse in OUD patients following detoxification from opioids Its product development programs are in non-clinical stages of development.

Events Timeline

(ET)

2025-06-03

08:48:58

Titan announces filing of registration statement for proposed combination

2024-11-27 (ET)

2024-11-27

15:07:30

Titan Pharmaceuticals receives Nasdaq notice of non-compliance

News

8.5

2025-08-27Benzinga

Titan Pharmaceuticals Shares Jump 23% in After-Hours Trading Following Stockholder Endorsement of Three-Way Merger

7.0

2025-08-06Globenewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SCS, HLVX, BSGM, TTNP on Behalf of Shareholders

7.0

2025-07-30Globenewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS, VBTX, TTNP on Behalf of Shareholders July 31, 2025

7.0

2025-07-29PRnewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BASE, SPTN, TTNP on Behalf of Shareholders

8.5

2025-07-29Globenewswire

URGENT: The M&A Class Action Firm Encourages $hareholders to Act Before Vote – Titan Pharmaceuticals, Inc. (Nasdaq: TTNP)

7.0

2025-07-26Globenewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CARM, ENZB, HSON, TTNP on Behalf of Shareholders

Valuation Metrics

The current forward P/E ratio for Titan Pharmaceuticals Inc (TTNP.O) is -0.49, compared to its 5-year average forward P/E of -0.91. For a more detailed relative valuation and DCF analysis to assess Titan Pharmaceuticals Inc 's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-0.91

Current PE

-0.49

Overvalued PE

-0.33

Undervalued PE

-1.49

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.02

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.11

Undervalued EV/EBITDA

-0.07

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

45.35

Current PS

0.47

Overvalued PS

122.94

Undervalued PS

-32.23

Financials

AI Analysis

Annual

Quarterly

Whales Holding TTNP

Trading Trends

People Also Watch

Frequently Asked Questions

What is Titan Pharmaceuticals Inc (TTNP) stock price today?

The current price of TTNP is 0 USD — it has increased 0 % in the last trading day.

What is Titan Pharmaceuticals Inc (TTNP)'s business?

What is the price predicton of TTNP Stock?

Wall Street analysts forecast TTNP stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for TTNP is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Titan Pharmaceuticals Inc (TTNP)'s revenue for the last quarter?

Titan Pharmaceuticals Inc revenue for the last quarter amounts to 0.00 USD, decreased % YoY.

What is Titan Pharmaceuticals Inc (TTNP)'s earnings per share (EPS) for the last quarter?

Titan Pharmaceuticals Inc. EPS for the last quarter amounts to -0.65 USD, decreased -71.62 % YoY.

How many employees does Titan Pharmaceuticals Inc (TTNP). have?

Titan Pharmaceuticals Inc (TTNP) has 4 emplpoyees as of February 07 2026.

What is Titan Pharmaceuticals Inc (TTNP) market cap?

Today TTNP has the market capitalization of 5.07M USD.

TTNP Overview